A carregar...
Preventative therapies for healthy women at high risk of breast cancer
Tamoxifen has been shown to reduce the risk of developing estrogen receptor (ER)-positive breast cancer by at least 50%, in both pre- and postmenopausal women. The current challenge is to find new agents with fewer side effects and to find agents that are specifically suitable for premenopausal wome...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4207437/ https://ncbi.nlm.nih.gov/pubmed/25378950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S55219 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|